Related Experiment Videos
Management of retroperitoneal sarcomas
R R Dalton1, J H Donohue, P Mucha
1Department of Surgery, Mayo Clinic Rochester, Minn 55905.
Surgery
|October 1, 1989
Summary
Complete surgical excision improves survival for retroperitoneal sarcomas, but recurrence remains a challenge. Achieving complete resection and managing tumor grade are key to better patient outcomes.
Area of Science:
- Surgical Oncology
- Sarcoma Research
- Retroperitoneal Tumors
Background:
- Retroperitoneal sarcomas are rare and aggressive tumors.
- Treatment outcomes are often limited by local recurrence and distant metastases.
Purpose of the Study:
- To analyze clinical, pathologic, and treatment variables influencing recurrence and survival in patients with retroperitoneal sarcomas.
- To identify prognostic factors for improved patient outcomes.
Main Methods:
- Retrospective review of 116 adult patients treated for retroperitoneal sarcomas (1963-1982).
- Analysis of tumor type, grade, stage, surgical excision status, recurrence, and survival data.
Main Results:
- Leiomyosarcomas, liposarcomas, and malignant fibrous histiocytomas comprised 93% of tumors.
- Complete excision was achieved in 54% of patients, with 68% experiencing recurrence.
- High-grade (G2-4) or fixed (T3) tumors increased recurrence risk.
- Five-year and 10-year survival rates were 40% and 22%, respectively.
Conclusions:
- Complete surgical excision is crucial for long-term survival in retroperitoneal sarcomas.
- Low tumor grade, non-fixed tumors, and absence of metastases at diagnosis are favorable prognostic indicators.
- Improving complete resection rates and reducing local recurrence are critical therapeutic challenges.